Feasibility Of Immunotherapy Using Donor Cd8+ T Cells Stimulated With Leukemic Cell- Or Donor Cd14+ Cell Derived Dendritic Cells (Dc) Against Leukemia Relapsing After Hematopoietic Stem Cell Transplantation (Hsct).
BLOOD（2001）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要